We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Nicole G Gaddi, B.Sc Nursing
+ 61 (0)428 946 588
nicole.gaddi@oncosil.com
Tom Maher
+44 750 4658585
tom.maher@oncosil.com
Neoplasms Pancreatic Neoplasms Neoplasms by Site Digestive System Neoplasms Gastrointestinal Neoplasms Endocrine Gland Neoplasms Digestive System Diseases Gastrointestinal Diseases Pancreatic Diseases Endocrine System Diseases
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
The OSPREY Patient Registry has been developed to collect and assess the performance and safety of the OncoSil™ device when used within the approved indication of unresectable, locally advanced pancreatic cancer, in combination with gemcitabine-based chemotherapy, within a real-world observational registry.
The Registry data will provide both complementary and contemporary information to the existing clinical data across various countries and will form part of the post-market clinical follow-up activities for OncoSil™. Therefore, the Registry will be implemented only in countries with regulatory (commercial) approval for the OncoSil™ device.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
You can take part if:
You may not be able to take part if:
This is in the inclusion criteria above
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Nicole G Gaddi, B.Sc Nursing
+ 61 (0)428 946 588
nicole.gaddi@oncosil.com
Tom Maher
+44 750 4658585
tom.maher@oncosil.com
The study is sponsored by OncoSil Medical Limited
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
